↓ Skip to main content

Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Double-Blind…

Overview of attention for article published in Advances in Therapy, March 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
66 Mendeley
Title
Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Double-Blind Randomized Trial
Published in
Advances in Therapy, March 2015
DOI 10.1007/s12325-015-0195-3
Pubmed ID
Authors

Linong Ji, Bernard Zinman, Sanjay Patel, Jinfeng Ji, Zelie Bailes, Sandra Thiemann, Thomas Seck

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 2%
Unknown 65 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 18%
Other 8 12%
Student > Master 7 11%
Student > Doctoral Student 4 6%
Researcher 3 5%
Other 12 18%
Unknown 20 30%
Readers by discipline Count As %
Medicine and Dentistry 25 38%
Pharmacology, Toxicology and Pharmaceutical Science 7 11%
Nursing and Health Professions 5 8%
Environmental Science 2 3%
Agricultural and Biological Sciences 2 3%
Other 3 5%
Unknown 22 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2019.
All research outputs
#6,536,702
of 23,576,969 outputs
Outputs from Advances in Therapy
#580
of 2,410 outputs
Outputs of similar age
#74,811
of 264,185 outputs
Outputs of similar age from Advances in Therapy
#6
of 22 outputs
Altmetric has tracked 23,576,969 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 2,410 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,185 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.